These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 46849)

  • 1. Comparsion of the properties of two antigen-induced guinea pig lymphokines.
    Ashworth LA; Eckersley BJ; Ford WH
    Int Arch Allergy Appl Immunol; 1975; 48(1):143-55. PubMed ID: 46849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphokines. I. Use of insoluble concanavalin A for the production of migration inhibitory factor in guinea pig lymphocyte cultures.
    Friedrich W; Lazary S; Geczy C; de Weck AL
    Int Arch Allergy Appl Immunol; 1975; 49(4):504-18. PubMed ID: 1099010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial purification of the cholestatic factor derived from the lymphocytes of tuberculin-sensitized guinea pigs.
    Mizoguchi Y; Ohnishi F; Monna T; Yamamoto S; Morisawa S
    Gastroenterol Jpn; 1981; 16(3):260-7. PubMed ID: 7021301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guinea pig lymphocyte-derived macrophage aggregation factor: its separation from macrophage migration inhibitory factor.
    Postlethwaite AE; Kang AH
    J Immunol; 1976 Nov; 117(5 Pt 1):1651-5. PubMed ID: 794415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphokine activity in vivo in relation to circulating monocyte levels and delayed skin reactivity.
    Yoshida T; Cohen S
    J Immunol; 1974 Apr; 112(4):1540-7. PubMed ID: 4131167
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of immunoglobulin receptors on lymphocytes in production of MIF in guinea pigs.
    GoĊ›cicka T
    Cell Immunol; 1974 Aug; 13(2):207-15. PubMed ID: 4141646
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on lymphokines: the production of antibody to guinea pig lymphotoxin and its use to distinguish lymphotoxin from migration inhibitory factor and mitogenic factor.
    Gately MK; Gately CL; Henney CS; Mayer MM
    J Immunol; 1975 Sep; 115(3):817-26. PubMed ID: 1097529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on migration inhibitory factor (MIF): recovery of MIF activity after purification by gel filtration and disc electrophoresis.
    Remold HG; Katz AB; Haber E; David JR
    Cell Immunol; 1970 May; 1(1):133-45. PubMed ID: 4108779
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanism of action of migration inhibitory factor (MIF). I. Evidence for a receptor for MIF present on the peritoneal macrophage but not on the alveolar macrophage.
    Leu RW; Eddleston AL; Hadden JW; Good RA
    J Exp Med; 1972 Sep; 136(3):589-603. PubMed ID: 4115133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage requirement for production of guinea pig migration inhibitory factor (MIF) in vitro.
    Nelson RD; Leu RW
    J Immunol; 1975 Feb; 114(2 Pt 1):606-9. PubMed ID: 47355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of guinea pig mitogenic factor.
    Mills JA
    J Immunol; 1975 Jan; 114(1 Pt 1):45-50. PubMed ID: 46245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification of guinea pig pH 3 migration inhibitory factor.
    Remold HG; McCarthy PL; Mednis AD
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4088-91. PubMed ID: 7027252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial purification and physicochemical properties of human T cell migration inhibitory factor (TIF).
    Kowalczyk D; Staykowa M; Litwora E; Pryjma J; Zembala M
    J Clin Lab Immunol; 1984 Oct; 15(2):105-10. PubMed ID: 6394762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and characterization of guinea pig lymphotoxin produced by lymph node cells stimulated by phytohemagglutinin.
    Sawada JI; Shioiri-Nakano K; Osawa T
    Transplantation; 1975 Apr; 19(4):335-42. PubMed ID: 239474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the concentration of inducing agent on the output of lymphokines in the guinea pig.
    Ford WH; Ashworth LA; Inder S
    Eur J Immunol; 1976 Feb; 6(2):135-8. PubMed ID: 786697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Migration inhibitory factor.
    Remold HG; Mednis AD
    Methods Enzymol; 1985; 116():379-94. PubMed ID: 3911018
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibodies to guinea pig lymphokines. III. Reactions with radiolabeled lymphocyte activation products.
    Sorg C; Geczy CL
    Eur J Immunol; 1976 Oct; 6(10):688-93. PubMed ID: 797284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of migration inhibitory factor (MIF) from guinea pig lymphocytes stimulated with concanavalin A.
    Remold HG; David RA; David JR
    J Immunol; 1972 Sep; 109(3):578-86. PubMed ID: 4115544
    [No Abstract]   [Full Text] [Related]  

  • 19. Mouse spleen cell-derived toxoplasma growth inhibitory factor: its separation from macrophage migration inhibitory factor.
    Nagasawa H; Igarashi I; Matsumoto T; Sakurai H; Marbella C; Suzuki N
    Immunobiology; 1980 Dec; 157(4-5):307-19. PubMed ID: 7005083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte-derived eosinophil chemotactic factor. II. Studies on the mechanism of activation of the precursor substance by immune complexes.
    Torisu M; Yoshida T; Ward PA; Cohen S
    J Immunol; 1973 Nov; 111(5):1450-8. PubMed ID: 4126774
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.